US 11,903,586 B2
Compressible adjunct with crossing spacer fibers
Michael J. Vendely, Lebanon, OH (US); Frederick E. Shelton, IV, Hillsboro, OH (US); Jason L. Harris, Lebanon, OH (US); Charles J. Scheib, Loveland, OH (US); Howell T. Goldrein, Cambridge (GB); Robert S. Moir, Cambridge (GB); Sofia Maria Consonni, Birmingham (GB); Ismail Akram, Cambridge (GB); Ashley D. Easter, Cambridge (GB); and Helen S. Latham, Cambridge (GB)
Assigned to Cilag GmbH International, Zug (CH)
Filed by Cilag GmbH International, Zug (CH)
Filed on Nov. 19, 2021, as Appl. No. 17/531,197.
Application 17/531,197 is a continuation of application No. 17/061,764, filed on Oct. 2, 2020, granted, now 11,553,916.
Application 17/061,764 is a continuation of application No. 16/229,607, filed on Dec. 21, 2018, granted, now 10,932,779, issued on Mar. 2, 2021.
Application 16/229,607 is a continuation of application No. 14/871,071, filed on Sep. 30, 2015, granted, now 10,433,846, issued on Oct. 8, 2019.
Prior Publication US 2022/0151614 A1, May 19, 2022
This patent is subject to a terminal disclaimer.
Int. Cl. A61B 17/10 (2006.01); A61B 17/072 (2006.01); A61B 17/064 (2006.01); B32B 5/02 (2006.01); B32B 5/10 (2006.01); B32B 5/12 (2006.01); B32B 5/18 (2006.01); B32B 5/24 (2006.01); B32B 5/26 (2006.01); B32B 3/02 (2006.01); B32B 3/08 (2006.01); B32B 3/20 (2006.01); B32B 3/26 (2006.01); B29C 48/16 (2019.01); A61B 17/00 (2006.01); A61B 17/32 (2006.01); A61B 17/08 (2006.01); A61L 17/10 (2006.01); A61L 17/12 (2006.01); B05D 1/00 (2006.01); B05D 1/30 (2006.01); D01D 5/00 (2006.01); D01D 5/18 (2006.01); D04H 1/56 (2006.01); B32B 7/05 (2019.01); A61B 17/068 (2006.01); B29L 31/00 (2006.01); B29C 44/34 (2006.01); B29C 48/05 (2019.01); B29C 48/00 (2019.01)
CPC A61B 17/105 (2013.01) [A61B 17/00491 (2013.01); A61B 17/068 (2013.01); A61B 17/0644 (2013.01); A61B 17/072 (2013.01); A61B 17/07207 (2013.01); A61B 17/07292 (2013.01); A61B 17/08 (2013.01); A61B 17/32 (2013.01); A61L 17/105 (2013.01); A61L 17/12 (2013.01); B05D 1/007 (2013.01); B05D 1/30 (2013.01); B29C 48/16 (2019.02); B32B 3/02 (2013.01); B32B 3/08 (2013.01); B32B 3/20 (2013.01); B32B 3/266 (2013.01); B32B 5/024 (2013.01); B32B 5/026 (2013.01); B32B 5/10 (2013.01); B32B 5/12 (2013.01); B32B 5/18 (2013.01); B32B 5/245 (2013.01); B32B 5/26 (2013.01); B32B 7/05 (2019.01); D01D 5/0023 (2013.01); D01D 5/18 (2013.01); D04H 1/565 (2013.01); A61B 2017/00004 (2013.01); A61B 2017/00477 (2013.01); A61B 2017/00526 (2013.01); A61B 2017/00831 (2013.01); A61B 2017/00862 (2013.01); A61B 2017/00893 (2013.01); A61B 2017/00955 (2013.01); A61B 2017/00964 (2013.01); A61B 2017/0725 (2013.01); A61B 2017/07214 (2013.01); A61B 2017/07221 (2013.01); A61B 2017/07228 (2013.01); A61B 2017/07235 (2013.01); A61B 2017/07242 (2013.01); A61B 2017/07257 (2013.01); A61B 2017/07271 (2013.01); A61B 2017/07278 (2013.01); A61B 2017/07285 (2013.01); A61L 2420/02 (2013.01); B29C 44/3453 (2013.01); B29C 44/358 (2013.01); B29C 48/0012 (2019.02); B29C 48/0022 (2019.02); B29C 48/05 (2019.02); B29L 2031/753 (2013.01); B29L 2031/7546 (2013.01); B32B 2250/03 (2013.01); B32B 2250/40 (2013.01); B32B 2307/50 (2013.01); B32B 2307/54 (2013.01); B32B 2307/72 (2013.01); B32B 2307/732 (2013.01); B32B 2307/736 (2013.01); B32B 2535/00 (2013.01); D10B 2331/041 (2013.01); D10B 2509/00 (2013.01)] 20 Claims
OG exemplary drawing
 
1. A staple cartridge assembly for use with a surgical stapling instrument, wherein the staple cartridge assembly comprises:
a staple cartridge, comprising:
a plurality of staples; and
a cartridge deck; and
a collapsible absorbable lattice positionable against the cartridge deck, wherein the staples are deployable into tissue captured against the collapsible absorbable lattice, and wherein the collapsible absorbable lattice comprises:
a first biocompatible layer;
a second biocompatible layer; and
standing fibers interconnecting the first biocompatible layer and the second biocompatible layer, wherein the standing fibers cooperatively maintain the first biocompatible layer away from the second biocompatible layer, and wherein the standing fibers comprise end portions embedded into the second biocompatible layer.